Guerbet SA (EPA: GBT)
France
· Delayed Price · Currency is EUR 25.00
+0.05 (0.20%)
Dec 20, 2024, 5:35 PM CET
Guerbet Revenue
Guerbet had revenue of 424.92M EUR in the half year ending June 30, 2024, with 13.56% growth. This brings the company's revenue in the last twelve months to 840.79M, up 8.48% year-over-year. In the year 2023, Guerbet had annual revenue of 795.65M with 3.40% growth.
Revenue (ttm)
840.79M
Revenue Growth
+8.48%
P/S Ratio
0.37
Revenue / Employee
287.94K
Employees
2,920
Market Cap
315.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 795.65M | 26.16M | 3.40% |
| Dec 31, 2022 | 769.50M | 33.59M | 4.56% |
| Dec 31, 2021 | 735.91M | 19.24M | 2.68% |
| Dec 31, 2020 | 716.67M | -102.33M | -12.49% |
| Dec 31, 2019 | 819.00M | 24.39M | 3.07% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |